These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors. Nakashima A, Kobayashi T, Terao T. Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712 [Abstract] [Full Text] [Related]
4. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130 [Abstract] [Full Text] [Related]
5. Fibrinolytic Changes in Women with Preeclampsia. Godtfredsen AC, Sidelmann JJ, Dolleris BB, Jørgensen JS, Johansen EKJ, Pedersen MFB, Palarasah Y, Gram JB. Clin Appl Thromb Hemost; 2022 Feb; 28():10760296221126172. PubMed ID: 36217728 [Abstract] [Full Text] [Related]
12. Maternal plasma plasminogen activator inhibitor-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Akolekar R, Cruz Jde J, Penco JM, Zhou Y, Nicolaides KH. Hypertens Pregnancy; 2011 Feb; 30(2):194-202. PubMed ID: 20205627 [Abstract] [Full Text] [Related]
13. Fibrinolysis parameters in Sudanese women with severe preeclampsia. Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I. Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010 [Abstract] [Full Text] [Related]